NCT01307449View on ClinicalTrials.gov

Systems Biology of PNEUMOVAX®23 and PREVNAR 13®

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Pneumococcal Infection
Interventions
BIOLOGICAL

PNEUMOVAX

1 dose of PNEUMOVAX

BIOLOGICAL

Prevnar

1 dose of Prevnar

Trial Locations (2)

30030

Hope Clinic of the Emory Vaccine Center, Decatur

30033

Atlanta VA Medical Center, Decatur

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Emory University

OTHER

NCT01307449 - Systems Biology of PNEUMOVAX®23 and PREVNAR 13® | Biotech Hunter | Biotech Hunter